Table 5_2_2.1
Adult patients with HIV and CD4 count ≤ 200 who received Pneumocystis pneumonia (PCP) prophylaxis,a United States, 2004 and 2006
| |
|
2006 |
2004 |
| Population group |
Percent |
SE |
Percent |
SE |
| Total |
|
93.2 |
0.6 |
85.2 |
0.7 |
| Age |
18–44 |
93.5 |
0.7 |
85.8 |
0.9 |
| 45 and over |
92.8 |
0.9 |
84.3 |
1.2 |
| Race |
Non-Hispanic, White |
92.1 |
1.2 |
86.8 |
1.4 |
| Non-Hispanic, Black |
93.2 |
0.8 |
83.9 |
1.1 |
| Hispanic |
94.7 |
1.2 |
86.1 |
1.6 |
| Other |
94.1 |
3.3 |
86.5 |
5.7 |
| Gender |
Male |
93.3 |
0.6 |
87.1 |
0.8 |
| Female |
92.9 |
1.2 |
79.3 |
1.7 |
| Health insurance |
Private |
93.9 |
1.8 |
81.7 |
3.0 |
| Medicaid |
93.2 |
0.9 |
83.1 |
1.3 |
| Medicare/dual eligible |
91.3 |
1.2 |
82.8 |
1.7 |
| Ryan White/uninsured |
94.8 |
0.9 |
90.0 |
1.1 |
a For HIV patients having at least two CD4 tests ≤ 200 during the year.
Key: SE: standard error.
Source: Agency for Healthcare Research and Quality, Center for Delivery, Organization, and Markets, HIV Research Network.